P496: PHENOTYPIC SUBTYPES OF LEUKEMIC TRANSFORMATION IN CHRONIC MYELOMONOCYTIC LEUKEMIA

• Guillermo Montalban-Bravo,
• Rashmi Kanagal-Shamanna,
• Ziyi LI,
• Danielle Hammond,
• Kelly Chien,
• Juan Jose Rodriguez-Sevilla,
• Koji Sasaki,
• Elias Jabbour,
• Courtney Dinardo,
• Koichi Takahashi,
• Nicholas Short,
• Ghayas Issa,
• Tapan Kadia,
• Naveen Pemmaraju,
• Farhad Ravandi,
• Naval Daver,
• Gautam Borthakur,
• Sanam Loghavi,
• Sherry Pierce,
• Carlos Bueso Ramos,
• Guillermo Garcia-Manero

Affiliations

Guillermo Montalban-Bravo

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Rashmi Kanagal-Shamanna

2 The University of Texas MD Anderson Cancer Center, Hematopathology, Houston, United States

Ziyi LI

3 The University of Texas MD Anderson Cancer Center, Biostatistics, Houston, United States

Danielle Hammond

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Kelly Chien

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Juan Jose Rodriguez-Sevilla

3 The University of Texas MD Anderson Cancer Center, Biostatistics, Houston, United States

Koji Sasaki

2 The University of Texas MD Anderson Cancer Center, Hematopathology, Houston, United States

Elias Jabbour

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Courtney Dinardo

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Koichi Takahashi

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Nicholas Short

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Ghayas Issa

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Tapan Kadia

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Naveen Pemmaraju

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Farhad Ravandi

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Naval Daver

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Gautam Borthakur

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Sanam Loghavi

2 The University of Texas MD Anderson Cancer Center, Hematopathology, Houston, United States

Sherry Pierce

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Carlos Bueso Ramos

2 The University of Texas MD Anderson Cancer Center, Hematopathology, Houston, United States

Guillermo Garcia-Manero

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States